Bradford T. Smith
Nessuna posizione attualmente
Profilo
Bradford T.
Smith has been Chief Legal Officer and Secretary of Laboratory Corp.
of America Holdings since September 2001 and Vice Chairman and a Director since January 2007.
Mr. Smith was Executive Vice President of Laboratory Corp.
of America Holdings from September 2001 to January 1, 2009.
Previously, he had served as Executive Vice President, General Counsel and Secretary of Laboratory Corp.
of America since April 1995.
Mr. Smith served as Chief Compliance Officer of Laboratory Corp.
of America from August 1996 to September 2001.
At Laboratory Corp.
of America, he oversees its Public Affairs, Human Resources, Law, Compliance, Public Policy, Audit, Risk Management, DNA Identification, Clinical Trials and Licensing Operations.
Mr. Smith held various senior management positions with Hoffmann-La Roche, including Assistant General Counsel from 1988 to 1995.
Currently, he is a Member of the Executive Committee for Laboratory Corp.
of America.
Precedenti posizioni note di Bradford T. Smith
| Società | Posizione | Fine |
|---|---|---|
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Consigliere Generale | 01/01/2009 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01/01/1995 |
| Roche Biomedical Laboratories, Inc. | Consigliere Generale | - |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Laboratory Corp. of America Holdings
 Laboratory Corp. of America Holdings Services to the Health IndustryHealth Services Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC. | Health Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
| Roche Biomedical Laboratories, Inc. | Health Technology |
- Borsa valori
- Insiders
- Bradford T. Smith